M.MonginiT.et al
While early data are promising, clinical evidence in dogs is still developing, making transparency and a rehabilitation-focused approach essential
His approach focuses on the non-surgical and utilizes cutting-edge technology for minimally invasive treatment of orthopedic injuries, including the use of stem cell therapy, platelet-rich-plasma (PRP), ultrasound, and percutaneous ultrasonic tenotomy
In rare cases, some people may have an allergic reaction
1. Longevity & Geroprotection
Advantage: Convenient, familiar, non-invasive Challenge: Peptides face proteolytic degradation in the stomach and small intestine Bioavailability: Estimated at approximately 38% based on comparative pharmacology (see below) Transdermal (Patch) Some researchers have explored transdermal patches to deliver peptides: Advantage: Avoids first-pass metabolism and GI degradation Challenge: Intact skin is a strong barrier to peptide penetration Feasibility: Not commonly available commercially